Lisata Therapeutics (LSTA) Return on Equity (2016 - 2025)
Historic Return on Equity for Lisata Therapeutics (LSTA) over the last 12 years, with Q3 2025 value amounting to 0.95%.
- Lisata Therapeutics' Return on Equity fell 3700.0% to 0.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.95%, marking a year-over-year decrease of 3700.0%. This contributed to the annual value of 0.51% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Lisata Therapeutics' Return on Equity is 0.95%, which was down 3700.0% from 0.82% recorded in Q2 2025.
- Lisata Therapeutics' Return on Equity's 5-year high stood at 0.34% during Q2 2023, with a 5-year trough of 0.95% in Q3 2025.
- Over the past 3 years, Lisata Therapeutics' median Return on Equity value was 0.52% (recorded in 2024), while the average stood at 0.57%.
- Its Return on Equity has fluctuated over the past 5 years, first surged by 400bps in 2024, then tumbled by -3700bps in 2025.
- Over the past 3 years, Lisata Therapeutics' Return on Equity (Quarter) stood at 0.41% in 2023, then tumbled by -53bps to 0.63% in 2024, then plummeted by -50bps to 0.95% in 2025.
- Its Return on Equity was 0.95% in Q3 2025, compared to 0.82% in Q2 2025 and 0.7% in Q1 2025.